We present a secondary analysis of our randomized clinical trial evaluating the effect of POC coagulopathy management and intraoperative administration of 5% albumin as primary resuscitative fluid during LuTx surgery on early lung allograft function, incidence of PGD, and 1-year survival. Here, ALB is linked to blood coagulation disease.